The Board of Directors of Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) has with great pleasure appointed Dr. Mervyn Cass...
Genetic Technologies Launches BREVAGen™ Breast Cancer Risk Test in US - A New Breast Cancer Predictive-Risk Genetic Test - first mover in...
Genetic Technologies Processes First BREVAGen™ Patient Sample Successfully tests logistics, analytical, IT and billing systems Moves closer to...
Genetic Technologies Files New Patent Infringement Suit in USA PR Newswire VICTORIA, Australia, May 26, 2011 VICTORIA, Australia, May 26, 2011...
Genetic Technologies Secures US Approval for Launch of BREVAGen™ Breast Cancer Risk Test - Genetic Technologies - first Australian CLIA approved...
GTG Announces New Product Collaboration with Global Pharmaceutical Company for Companion Diagnostics in Oncology PR Newswire VICTORIA, Australia...
Rosetta Genomics, Ltd. (NASDAQ:ROSG), a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies...
Genetic Technologies Limited (NASDAQ:GENE)(ASX:GTG) is pleased to announce that, for the first time in the Company?s history...
Genetic Technologies Limited (NASDAQ:GENE) (ASX:GTG) today launched a new dog attack DNA kit that will allow Australian rangers...
Genetic Technologies Limited (NASDAQ GM: GENE; ASX: GTG) today announced that, following the recent appointment of Mr. David...
Genetic Technologies Limited (NASDAQ:GENE)(ASX:GTG) today announced that it had received a letter of non-compliance with Nasdaq?s...
Genetic Technologies Limited (NASDAQ:GENE)(ASX:GTG) is pleased to provide the Market with a further progress report on its...
Genetic Technologies Limited ("GTG") (NASDAQ:GENE) (ASX:GTG) is pleased to announce that it has executed a Memorandum of Understanding with...
Genetic Technologies Limited ("GTG") (NASDAQ:GENE) (ASX:GTG) is pleased to announce that it has now appointed the law firm of Doralt Seist...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.